Literature DB >> 20940196

Paraneoplastic hepatic dysfunction in metastatic prostate cancer: the role of cytokine dysregulation.

Vi Nguyen1, Howard Gurney, David van der Poorten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20940196     DOI： 10.1200/JCO.2010.30.6522

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Idiopathic cholestatic jaundice may be a paraneoplastic manifestation of underlying malignancy: a case of prostate cancer.

Authors:  Akihiro Okano; Masaya Ohana; Fusako Kusumi
Journal:  Clin J Gastroenterol       Date:  2014-04-12

2.  Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer Aggravated by Steroid Therapy.

Authors:  Min Kyu Kang; Jung Gil Park; Heon Ju Lee
Journal:  Med Princ Pract       Date:  2018-01-10       Impact factor: 1.927

3.  Paraneoplastic hyperbilirubinemia in metastatic prostate cancer and review of the current literature.

Authors:  Pınar Gökçen; Kaan Gökçen; Erol Çakmak; Gökhan Gökçe
Journal:  Turk J Urol       Date:  2018-09-12

4.  Hepatic Dysfunction as a Paraneoplastic Manifestation of Metastatic Prostate Adenocarcinoma.

Authors:  David Kato; Chinemerem Okwara; Christopher Moreland; Allan Parker
Journal:  J Investig Med High Impact Case Rep       Date:  2014-06-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.